Quarterly report pursuant to Section 13 or 15(d)

Other current assets

v3.21.2
Other current assets
9 Months Ended
Sep. 30, 2021
Other current assets  
Other current assets

Note 8 — Other current assets

Other current assets consisted of the following (in thousands):

September 30, 

December 31, 

    

2021

    

2020

Corporate tax receivable

 

$

43,446

 

$

20,585

Prepayments

 

9,970

 

6,314

Clinical materials

 

1,285

 

2,086

Other current assets

 

3,988

 

811

$

58,689

$

29,796